Information about Solipharma Vastgoed
My details
*
*
*

Solipharma Vastgoed (SRL)

nl

20128639

Company information

Status
Active

KVK number

20128639

VAT Number

NL 817352740 B01
Established
12-12-2006
Last balance sheet year
2025
Company size
Medium-sized 105 FTE
RSIN number
817352740
Principal activity
Activiteiten van financiële holdings
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Solipharma Vastgoed

2025 2024 2023 2022
Profit/Loss € 540.527 -45,38% € 989.699 -1,81% € 1.007.912 44,39% € 698.041
Turnover - € 10.948.443 - -
Equity € 4.970.962 -3,87% € 5.170.910 5,06% € 4.921.685 5,41% € 4.669.254
Gross margin € 11.190.681 2,21% € 10.948.443 4,16% € 10.511.608 17,64% € 8.935.346
Employees 105 100 100 92

Frequently asked questions

What is the KVK number of Solipharma Vastgoed?
The KVK number of Solipharma Vastgoed is 20128639
What is the VAT number of Solipharma Vastgoed?
The VAT number of Solipharma Vastgoed is NL 817352740 B01.
Wat is the PEPPOL ID of Solipharma Vastgoed?
There is no information available about the PEPPOL ID of Solipharma Vastgoed or the company is not yet registered on the PEPPOL network.
When was Solipharma Vastgoed founded?
Solipharma Vastgoed was founded on 12-12-2006.
What is the address of Solipharma Vastgoed?
The current registered office of Solipharma Vastgoed is located at Industrieweg 11/a, 4731 SB Oudenbosch.
When was the last time Solipharma Vastgoed filed their annual financial statements?
The most recent financial statements of Solipharma Vastgoed were filed on 31-12-2025.
How many employees does Solipharma Vastgoed have?
There are 105 FTEs working at Solipharma Vastgoed according to the staff figures in the most recent financial statements.
What is the annual turnover of Solipharma Vastgoed?
There is no turnover available for Solipharma Vastgoed.

Sources